Ovid Therapeutics
Patents, Design & Utilities

Last updated:

List of all Ovid Therapeutics patents 59 in total

Status Patent
Application
Utility: USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 10 Oct 2019
Application
Utility: USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF EYE DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 3 Oct 2019
Grant
Utility: Methods of treating developmental disorders with biguanides External link
Filling date: 6 Sep 2025 Issue date: 1 Oct 2019
Grant
Utility: Methods of treating developmental disorders and/or seizure disorders with etifoxine External link
Filling date: 6 Sep 2025 Issue date: 24 Sep 2019
Application
Utility: METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL External link
Filling date: 6 Sep 2025 Issue date: 22 Aug 2019
Application
Utility: METHODS OF TREATING DEVELOPMENTAL SYNDROMES WITH PDE10A INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 15 Aug 2019
Application
Utility: USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, MENIERE'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADDICTION External link
Filling date: 6 Sep 2025 Issue date: 8 Aug 2019
Grant
Utility: Methods and compositions for treatment of epileptic disorders External link
Filling date: 6 Sep 2025 Issue date: 30 Jul 2019

Showing 50 to 59 of 59 patents.